Literature DB >> 2003181

Diagnosis and pitfalls in the treatment of parotid tumors.

R H Spiro1.   

Abstract

Any swelling near the ear is best considered a parotid neoplasm until proved otherwise. The diagnosis is primarily based on the clinical examination. Imaging studies are best reserved for patients who present with palate or tonsil swellings, which must be distinguished from parapharyngeal or minor salivary gland tumors. Almost all benign, and most malignant parotid tumors can be resected with preservation of the facial nerve. Aspiration biopsy can add useful information, but is not essential for treatment planning as the extent of the surgical procedure is primarily determined by the extent of the tumor. Survival rates in patients with malignant tumors are most significantly influenced by tumor stage. Results seem to have improved in recent years, possibly because we are treating a larger proportion with favorable lesions. Another factor may relate to the enhancement of locoregional control now achieved with postoperative radiotherapy, particularly in patients with Stage III or IV tumors.

Entities:  

Mesh:

Year:  1991        PMID: 2003181     DOI: 10.1002/ssu.2980070106

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  5 in total

1.  An extremely rare case of metastatic retinoblastoma of parotids presenting as a massive swelling in a child.

Authors:  Abhishek Purkayastha; Neelam Sharma; Abhishek Pathak; Bhupendra Nath Kapur; Vibha Dutta
Journal:  Transl Pediatr       Date:  2016-04

2.  Radiotherapy for parotid cancer.

Authors:  L M Toonkel; S Guha; P Foster; V Dembrow
Journal:  Ann Surg Oncol       Date:  1994-11       Impact factor: 5.344

Review 3.  Usefulness of fine-needle aspiration in parotid diagnostics.

Authors:  Attilio Carlo Salgarelli; Paolo Capparè; Pierantonio Bellini; Marco Collini
Journal:  Oral Maxillofac Surg       Date:  2009-12

4.  The radiologic (CT/MRI)-pathological correlations of the salivary duct carcinoma (SDC) with hyaline degeneration and peripheral nerve invasion.

Authors:  Nobukata Kazawa; Yuta Shibamoto; Yasujirou Hirose; Yoriko Yamashita
Journal:  Dentomaxillofac Radiol       Date:  2021-04-20       Impact factor: 3.525

5.  Cystadenocarcinoma of the parotid: case report of a BRAF inhibitor treatment.

Authors:  Sabrina Boyrie; Isabelle Fauquet; Michel Rives; Caroline Genebes; Jean-Pierre Delord
Journal:  Springerplus       Date:  2013-12-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.